Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Archive
Top Five Countries to Watch for International Cannabis Reform in 2024
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
[Webinar] Identifying International Cannabis Opportunities in Europe
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
[Vicente LLP Event] Minnesota Hemp & Cannabis Seminar
Sep 18, 2023
Join the Vicente LLP team in Minneapolis for another can’t-miss hemp and cannabis legal and business seminar on October 19, 2023. The event will feature Vicente LLP hemp and cannabis business attorneys Michelle Bodian, Travis Copenhaver, Jeremy Shaw and Jason Tarasek, along with special guests Sen. Lindsey Port and cannabis accountant Angela L’Esperance of Ms. Jane Accounting.
Where Does the Texas Hemp Industry Go After the 2023 Legislative Session?
By Katelin Edwards, Andrea Golan
Aug 1, 2023
Between an unfavorable court ruling and an uninspiring 2021 legislative session, not to mention a major drought impacting all Texas crops, things were not looking good for hemp in Texas going into the 2023 legislative session. Then, many of the promising bills introduced in the 2023 legislative session were unsuccessful. Where does the Texas hemp market go from here? Read this article for four predictions from Vicente's hemp team.
Regulating Intoxicating Hemp Products: Recent Reports and Recommendations from Vermont, Maryland, Virginia and Oregon
By Sam Kovach-Orr
Jan 23, 2023
Vermont, Maryland, Virginia, Oregon, and Colorado recently issued reports containing policy recommendations relating to intoxicating hemp-derived products.
10 Key Takeaways from the Colorado Intoxicating Hemp Task Force Final Report
By Catie Wightman
Jan 17, 2023
The SB 22-205 Intoxicating Hemp Task Force's final report makes legislative and rule recommendations concerning the regulation of intoxicating and synthetic hemp products in Colorado. We compiled 10 key takeaways for hemp industry stakeholders.
High-THC Hemp Edibles Are Dangerous and Potentially Deadly: A Cautionary Tale in Minnesota
By Andrea Golan
Jan 6, 2023
Minnesota hemp companies are being sued by the Minnesota Board of Pharmacy for selling high-THC hemp-derived edibles that allegedly contained 100 milligrams of hemp-derived THC per gummy bear and were intentionally marketed in a manner that is appealing to children. What standards may lower consumer safety risks for these products?
[Webinar] Intoxicating Hemp Regulations: Where We Are and What's to Come
Dec 15, 2022
Watch as Vicente Sederberg LLP and EARTH Law LLC discuss the regulatory approaches for intoxicating hemp in Colorado, Oregon and California, and our projections for the future
Recent FDA Enforcement Letters Signal Increased FDA Scrutiny of Hemp Products
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
Vicente Sederberg LLP Hemp Update: July 2022
Jul 28, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
FDA Enforcement Action Targeted at Hemp-Derived Delta-8 Products
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
HIA v DEA Lawsuit: The Hemp Industry Needs Your Support to End DEA Overreach
Apr 14, 2022
Update on the lawsuit HIA & RE Botanicals, Inc v. DEA and why this case is critical to the hemp industry's future.
Vicente Sederberg LLP Hemp Update: April 2022
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
[Webinar] Minor Cannabinoids & Trending Topics in Hemp
Apr 1, 2022
Watch this session exploring trending topics in hemp. During the session, members of our hemp team dive into the legality, regulation, and lawsuits surrounding minor cannabinoids, current federal hemp legislation, and what we expect and hope to see in the 2023 Farm Bill.
Seven Regulatory-related Factors for Marijuana Companies to Consider in a Debt Transaction
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
Raising Private Capital in the Cannabis Industry
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.